Blue Cap reported a strong set of FY19 results, with revenues up 28% and adjusted EBITDA up 67%. Portfolio NAV increased 8% to €128.6m or €32.31 per share, which was mainly driven by expansion in the plastics segment. The coronavirus crisis has affected Blue Cap as management now expects a low double-digit organic decline in revenues in 2020. This will not be fully compensated for by the revenue contribution of acquired Con-Pearl. 2021 is expected to be much stronger, assuming a post-coronavirus recovery leading to increased activity, and the restructuring benefits at Con-Pearl.Den vollständigen Artikel lesen ...
© 2020 Edison Investment Research
